logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

BG Medicine (BGMD) Stock Plunges as Market Corrects for Pricing of Public Offering

By  +Follow April 3, 2014 10:47AM
Share:
Tickers Mentioned:

Shares in small-cap health care company BG Medicine (BGMD) plunged Thursday after the company priced the 6.45 million shares it plans to sell in a public offering.

The announcement, which came prior to the opening bell, led to the stock gapping down over 14 percent to $1.65 once markets opened. Shares continued to decline during morning trading, eventually settling at about $1.60 apiece.

It’s hard to view the big decline as a vote of no-confidence in BG Medicine from the markets. Shares are still trading hands at a value above the newly priced stock offering. What’s more, the public offering represents a significant increase in the size of BG Medicine’s float. Currently sitting at just under 28 million, the float would increase 23.1 percent to 34.372 million shares, and that’s not factoring in the 967,800 additional shares being held back for over-allotments.

This injection of liquidity becomes all the more important when one considers the high rate of insider ownership, which may have already resulted in pent-up demand driving big price swings. Insider ownership exceeds 40 percent of the float and has increased by more than 25 percent over the last half-year. As a result, one can roughly calculate that the free float for BG Medicine is set to increase by anywhere from 38.9 percent to 44.8 percent, resulting in a major injection of liquidity into the stock.

With this sort of boost in the total number of shares, combined with the pricing at $1.55 for the new shares, the day’s losses would appear to represent markets simply resetting their valuation for the new shares rather than showing any real concern about BG Medicine’s future.

BG Medicine has shown growing revenues, year-over-year, since 2010, and recently got a new vote of confidence in its BGM Galectin-3® Test from the Centers for Medicare and Medicaid Services (CMS) raised the national limitation amount (NLA) for the test, which has demonstrated the potential to substantially reduce the readmission rate of patients suffering from heart failure in studies.

BG Medicine already made big gains this year on a strong earnings report, and its potential for future earnings appears to be relatively strong. The sale of $10 million in new stock is expected to net $8.9 million for BG Medicine, potentially more if the over-allotments are all ultimately distributed, which the company plans to spend on commercializing its cardiac diagnostics tests, building the clinical case for its tests, and developing its product pipeline.

The public offering is expected to close by April 8, with underwriter Lazard Capital Markets LLC offering the over-allotment shares for an additional 30 days afterwards.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for BGMD
Cheds Trading
5 Mar 15 07:06:55
@BigCheds $BGMD looking excellent from my .70 entry call here http://t.co/vHpxAjzHFM
igor Bracislacislav
5 Mar 15 07:02:56
$BGMD there is movement
sbastrade
5 Mar 15 07:01:08
$BGMD buyers
Pablo Chick'n Stock
5 Mar 15 05:01:22
RT @BigCheds: on watch today $GRNH $VAPE $FORC $MBHC $IJJP $TRTC $GRCU $ECGI $OCLG $VPOR $CBIS $BGMD
Anonymos P.
5 Mar 15 04:59:36
RT @BigCheds: on watch today $GRNH $VAPE $FORC $MBHC $IJJP $TRTC $GRCU $ECGI $OCLG $VPOR $CBIS $BGMD
Cheds Trading
5 Mar 15 04:37:21
on watch today $GRNH $VAPE $FORC $MBHC $IJJP $TRTC $GRCU $ECGI $OCLG $VPOR $CBIS $BGMD
Stockaholics
5 Mar 15 02:09:08
400% Gains On Our Stock Picks & a MASSIVE New Pick Coming today! Check it out: http://t.co/IL8yCE0CRE $SLP $BGMD $DEQI
Penny Stock Secret
5 Mar 15 00:20:32
Yesterday We Made $89,000 In Just One Trade More Info Here http://t.co/NovWYe2RAx .. $TICC $BGMD $ICEL
Greg David
5 Mar 15 00:18:27
http://t.co/RMvVXnJDpv does trade alerts differently than anyone else. Its super cool. $EJ $EPXY $TRTC $CYTX $BGMD
				
				
By  +Follow April 3, 2014 10:47AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.